Detalhe da pesquisa
1.
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients.
N Engl J Med
; 386(6): 509-520, 2022 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34914868
2.
Impact of Molnupiravir Treatment on Patient-Reported COVID-19 Symptoms in the Phase 3 MOVe-OUT Trial: A Randomized, Placebo-Controlled Trial.
Clin Infect Dis
; 77(11): 1521-1530, 2023 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37466374
3.
Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trial.
Infection
; 51(5): 1273-1284, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36648627
4.
Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19 : A Randomized, Placebo-Controlled Trial.
Ann Intern Med
; 175(8): 1126-1134, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35667065
5.
Exposure-Efficacy Analyses Support Optimal Dosing Regimens of Ceftolozane/Tazobactam in Participants with Hospital-Acquired/Ventilator-Associated Bacterial Pneumonia in ASPECT-NP.
Antimicrob Agents Chemother
; 66(5): e0139921, 2022 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35471040
6.
Efficacy and safety of tedizolid for the treatment of ventilated gram-positive hospital-acquired or ventilator-associated bacterial pneumonia in Japanese patients: Results from a subgroup analysis of a phase 3, randomized, double-blind study comparing tedizolid and linezolid.
J Infect Chemother
; 28(9): 1235-1241, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35718656
7.
A Phase 3, Randomized, Double-Blind Study Comparing Tedizolid Phosphate and Linezolid for Treatment of Ventilated Gram-Positive Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia.
Clin Infect Dis
; 73(3): e710-e718, 2021 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33720350
8.
Population Pharmacokinetics, Exposure-Response, and Probability of Target Attainment Analyses for Tedizolid in Adolescent Patients with Acute Bacterial Skin and Skin Structure Infections.
Antimicrob Agents Chemother
; 65(12): e0089521, 2021 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34516243
9.
A multicenter analysis of the clinical microbiology and antimicrobial usage in hospitalized patients in the US with or without COVID-19.
BMC Infect Dis
; 21(1): 227, 2021 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33639862
10.
Ceftolozane/tazobactam probability of target attainment and outcomes in participants with augmented renal clearance from the randomized phase 3 ASPECT-NP trial.
Crit Care
; 25(1): 354, 2021 10 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34600585
11.
Molnupiravir for Covid-19 in Nonhospitalized Patients. Reply.
N Engl J Med
; 386(13): e32, 2022 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35294808
12.
Early Clinical Response as a Predictor of Late Treatment Success in Patients With Acute Bacterial Skin and Skin Structure Infections: Retrospective Analysis of 2 Randomized Controlled Trials.
Clin Infect Dis
; 64(2): 214-217, 2017 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28003218
13.
Clinical Response of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections by Severity Measure Using a Pooled Analysis from Two Phase 3 Double-Blind Trials.
Antimicrob Agents Chemother
; 61(5)2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28264845
14.
Reply to Chao and Lai.
Clin Infect Dis
; 73(8): 1552-1553, 2021 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33993256
15.
Analysis of the phase 3 ESTABLISH trials of tedizolid versus linezolid in acute bacterial skin and skin structure infections.
Antimicrob Agents Chemother
; 59(2): 864-71, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25421472
16.
Tedizolid phosphate for the management of acute bacterial skin and skin structure infections: efficacy summary.
Clin Infect Dis
; 58 Suppl 1: S43-50, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24343832
17.
Myelosuppression with Oxazolidinones: Are There Differences?
Antimicrob Agents Chemother
; 63(1)2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30578404
18.
Molnupiravir: Mechanism of action, clinical, and translational science.
Clin Transl Sci
; 17(2): e13732, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38593352
19.
Respiratory virus coinfections during the COVID-19 pandemic: epidemiologic analysis and clinical outcomes from the Phase 2/3 molnupiravir trial (MOVe-OUT).
Microbiol Spectr
; 12(3): e0356323, 2024 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38299867
20.
Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial.
JAMA
; 309(6): 559-69, 2013 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-23403680